COMMUNIQUÉS West-GlobeNewswire

Scilex Holding Company Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch

13/01/2025 - 15:00

More patients treated with ZTlido ® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% vs. 45.5%). Of all study patients reporting a decrease in opioid use, [...]

Clinical Trial of NeuroSigma’s Monarch eTNS System for ADHD at King’s College London Completes Enrollment

13/01/2025 - 15:00

ATTENS (ADHD trial of external trigeminal nerve stimulation) Project , led by Professor Katya Rubia at the Institute of Psychiatry, Psychology & Neuroscience is a multicentre , double-blind, placebo-controlled [...]

ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9

13/01/2025 - 15:00

The new Express License service removes barriers to accessing this transformative gene editing technology for startups. An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio [...]

Biomea Fusion to Become a Diabetes & Obesity Medicines Company

13/01/2025 - 15:00

Icovamenib & BMF-650 (oral small molecule GLP-1) are the cornerstones of the metabolic franchise Biomea preparing icovamenib for late-stage clinical development 2025 corporate update to be presented at the 43 rd [...]

New Standard for Medtech Alternate Equipment Management (AEM)

13/01/2025 - 14:57

AAMI Document Clarifies Repair Requirements Arlington, VA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Alternate equipment management (AEM) plans for medical devices can create friction between original equipment manufacturers ( [...]

Novo Nordisk A/S - share repurchase programme

13/01/2025 - 14:52

Bagsværd, Denmark, 13 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]

OneMedNet Regains Compliance with NASDAQ Listing Requirements

13/01/2025 - 14:50

MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World [...]

SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles

13/01/2025 - 14:41

TEL AVIV, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors Ltd., (“AutoMax”), a leading automotive importer and distributor in Israel with [...]

Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook

12/01/2025 - 22:00

2024 Total Revenue of $528M, Representing Significant Growth of 32% Year-Over-Year 1 Strong and Growing Demand for Galafold ® and Pombiliti ® + Opfolda ® Total Revenue Growth of 17-24% at CER Expected in 2025 >3,000 [...]

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

12/01/2025 - 18:00

New biomarkers on track for commercial launch in January 2025 Preliminary financial results indicate record full-year revenue and AVISE CTD trailing twelve-month ASP, with improvements to adjusted EBITDA and cash burn [...]

Mereo BioPharma Provides Update on Lead Clinical Programs

12/01/2025 - 17:05

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat, for Alpha-1 Antitrypsin Deficiency-associated Lung Disease, receives positive [...]

Ultragenyx Reports Preliminary 2024 Revenue, Financial Guidance for 2025, Pipeline Updates, and 2025 Milestones

12/01/2025 - 17:00

Preliminary 2024 total revenue of $555 million to $560 million, exceeding top end of guidance, including Crysvita® revenue of $405 million to $410 million, and Dojolvi® revenue of $87 million to $89 million 2025 [...]

Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine

12/01/2025 - 16:00

-- One year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to Shingrix SEATTLE, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately- [...]

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

12/01/2025 - 15:30

ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million

12/01/2025 - 14:30

Preliminary unaudited product revenue for the fourth quarter of 2024 is expected to be approximately $63 million, up approximately 366% vs. Q4 2023 and 41% vs. Q3 2024 Preliminary unaudited product revenue for the full- [...]

Lipozem: Introducing Lipozem as the Bizarre Turmeric Hack for Weight Loss Support

12/01/2025 - 08:18

LAKELAND, Fla., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Lipozem emerges in an era where weight management solutions seem endless—from strict diets to high-intensity workouts—yet one groundbreaking discovery is rapidly gaining [...]

iTeos annonce ses priorités stratégiques et ses étapes clés prévues pour 2025

11/01/2025 - 14:39

- Plusieurs extractions de données cliniques issues du programme TIGIT attendues en 2025, portant sur plus de 400 patients issus de deux essais de Phase II et d’un essai de Phase I/II évaluant l’association belrestotug [...]

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10/01/2025 - 23:15

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]

Matinas BioPharma Receives NYSE Noncompliance Notice

10/01/2025 - 23:15

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that on January 6, 2025, it received a NYSE American LLC notice indicating that the Company has [...]